Contrast Nephropathy in Oncology

Contrast nephropathy, also known as contrast-induced nephropathy (CIN), occurs when kidney function declines after the use of contrast agents, often used in imaging tests like CT scans. In oncology, patients frequently undergo these tests for diagnosis and treatment monitoring. Risk factors include pre-existing kidney issues and dehydration. Symptoms can include decreased urine output and elevated creatinine levels. It's crucial for healthcare providers to assess kidney health beforehand and take preventive measures, such as ensuring hydration, to minimize the risk of this complication when imaging cancer-related conditions.